End-of-Treatment Smoking Cessation Among African American Female Participants in the Breathe FreeTM for Women Smoking Cessation Program: Results of a Pilot Study

Fernander, Anita; Bush, Heather; Goldsmith-Mason, Shakira; White, Pamela J.; Obi, Brittaney

doi:10.1016/s0027-9684(15)31070-1

Cited by 5 publications

(5 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Various efforts have been put forward in the last decade to minimize racial disparities in cancer treatment and outcomes, including efforts by the NCI and both community-based and national smoking cessation programs geared towards minorities [32][33][34][35]. Increased emphasis on patient navigator programs by the NCI have been successful in improving timely access to quality care, but have not yet been implemented in lung cancer [36].…”

Section: Discussionmentioning

confidence: 99%

Racial disparities in the use of SBRT for treating early-stage lung cancer

et al. 2015

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Racial disparities in the use of SBRT for treating early-stage lung cancer

et al. 2015

View full text Add to dashboard Cite

“…A wide variety of evidence-based public health and clinical interventions are available to help people quit smoking, as systematically reviewed by the Guide to Community Preventive Services and the U.S. Preventive Services Taskforce ( http://www.thecommunityguide.org/index.html ; http://www.uspreventiveservicestaskforce.org/recommendations.htm ). Culturally appropriate interventions have been developed to help African Americans stop smoking [ 37 – 42 ]. Other interventions are especially well-suited for patients who have been diagnosed with lung cancer or other tobacco-related illness [ 36 , 43 , 44 ].…”

Section: Cigarette Smoking and Other Risk Factors For Lung Cancermentioning

confidence: 99%

Opportunities to address lung cancer disparities among African Americans

et al. 2014

View full text Add to dashboard Cite

Race and socioeconomic status are well known to influence lung cancer incidence and mortality patterns in the U.S. Lung cancer incidence and mortality rates are higher among blacks than whites. In this article we review opportunities to address disparities in lung cancer incidence, mortality, and survivorship among African Americans. First, we summarize recent advances in the early detection and treatment of lung cancer. Then we consider black-white disparities in lung cancer treatment including factors that may contribute to such disparities; the literature on smoking cessation interventions for patients with or without a lung cancer diagnosis; and the important roles played by cultural competency, patient trust in their physician, and health literacy in addressing lung cancer disparities, including the need for culturally competent lung cancer patient navigators. Intervention efforts should focus on providing appropriate quality treatment for lung cancer and educating African Americans about the value of having these treatments in order to reduce these disparities. Culturally competent, patient navigation programs are needed that support lung cancer patients, especially socioeconomically disadvantaged patients, from the point of diagnosis to the initiation and completion of treatment, including cancer staging.

show abstract

“…Additionally, racial bias has been seen in screening and smoking cessation programs, and clinics with more than 50% White patients enrollment are more likely to offer smoking cessation, which is not the case with AAs [23]. The negative impact of smoking on treatment and survival outcomes is well established; however, 50-83% of patients diagnosed with lung cancer continue to smoke [22,24,25]. Compared to other ethnic groups, AAs have lower rates of quitting [22,24,26,27].…”

Section: Smoking Pattern and Lung Cancer Disparitymentioning

confidence: 99%

“…The negative impact of smoking on treatment and survival outcomes is well established; however, 50-83% of patients diagnosed with lung cancer continue to smoke [22,24,25]. Compared to other ethnic groups, AAs have lower rates of quitting [22,24,26,27].…”

Section: Smoking Pattern and Lung Cancer Disparitymentioning

confidence: 99%

Social and Biological Determinants in Lung Cancer Disparity

Brock,

Mir,

Flenaugh

et al. 2024

Cancers

View full text Add to dashboard Cite

Lung cancer remains a leading cause of death in the United States and globally, despite progress in treatment and screening efforts. While mortality rates have decreased in recent years, long-term survival of patients with lung cancer continues to be a challenge. Notably, African American (AA) men experience significant disparities in lung cancer compared to European Americans (EA) in terms of incidence, treatment, and survival. Previous studies have explored factors such as smoking patterns and complex social determinants, including socioeconomic status, personal beliefs, and systemic racism, indicating their role in these disparities. In addition to social factors, emerging evidence points to variations in tumor biology, immunity, and comorbid conditions contributing to racial disparities in this disease. This review emphasizes differences in smoking patterns, screening, and early detection and the intricate interplay of social, biological, and environmental conditions that make African Americans more susceptible to developing lung cancer and experiencing poorer outcomes.

show abstract

End-of-Treatment Smoking Cessation Among African American Female Participants in the Breathe FreeTM for Women Smoking Cessation Program: Results of a Pilot Study

Cited by 5 publications

References 21 publications

Racial disparities in the use of SBRT for treating early-stage lung cancer

Racial disparities in the use of SBRT for treating early-stage lung cancer

Opportunities to address lung cancer disparities among African Americans

Social and Biological Determinants in Lung Cancer Disparity

Contact Info

Product

Resources

About